-
1 Comment
Surgery Partners, Inc is currently in a long term uptrend where the price is trading 61.5% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.1.
Surgery Partners, Inc's total revenue rose by 6.0% to $548M since the same quarter in the previous year.
Its net income has increased by 128.6% to $6M since the same quarter in the previous year.
Finally, its free cash flow fell by 410.0% to $-6M since the same quarter in the previous year.
Based on the above factors, Surgery Partners, Inc gets an overall score of 4/5.
Exchange | NASDAQ |
---|---|
CurrencyCode | USD |
ISIN | US86881A1007 |
Sector | Healthcare |
Industry | Medical Care Facilities |
Beta | 2.4 |
---|---|
Target Price | 31.3636 |
Market Cap | 3B |
PE Ratio | None |
Dividend Yield | None |
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; and ancillary services, such as multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for SGRY using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025